Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 22, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - September 22, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 17 of 17     Go To Page:

9/21/18 - Contact Lenses Classified as Medical Devices by the FDA, Prescriptions Required for Purchase [Syrian Arab News Agency]
-According to the Centers for Disease Control and Prevention, an estimated 45 million people in the United States wear contact lenses. Many consumers may not be aware that contact lenses are medical devices and are regulated by the U.S. Food and Drug Administration through the Federal Food, Drug, and Cosmetic Act. Additionally, the FDA states that
9/20/18 - ACCC won't oppose Arrow and Apotex merger
Combined, they will supply around half the market for generic prescription pharmaceuticals to pharmacies in Australia. However, we found that a combined Arrow-Apotex would continue to face strong competition from Mylan and Sandoz, and to a lesser extent from short range suppliers like Generic Health and Pharmacor. These suppliers are backed by stro
9/20/18 - AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause
AMAG Pharmaceuticals, Inc. today announced that together with Emmy - nominated actress Cheryl Hines and leading family medicine and menopause expert, Marla Shapiro, MD, it is launching an integrated campaign to start an open dialogue about painful sex due to menopause, a topic that is often not talked about among post-menopausal women and their
9/20/18 - Apple Watch received FDA clearance just one day before the launch; cardiologist questions ECG accuracy [T-break Tech (Middle East)]
Apple made a big deal of the ECG functionality of the Apple Watch Series 4, and emphasized that the feature had received FDA clearance. Some on the Apple Watch team may have felt their hearts pounding in the days leading up to the big Apple Watch 4 unveiling in Cupertino last week. I overheard an Apple employee talking about the near-miss in exaspe
9/20/18 - Contact Lenses Classified as Medical Devices by the FDA, Prescriptions Required for Purchase
According to the Centers for Disease Control and Prevention, an estimated 45 million people in the United States wear contact lenses. Many consumers may not be aware that contact lenses are medical devices and are regulated by the U.S. Food and Drug Administration through the Federal Food, Drug, and Cosmetic Act. And, always wear contact lenses und
9/20/18 - Many are familiar with tetrahydrocannabinol, or THC, the can
Many are familiar with tetrahydrocannabinol, or THC, the cannabis plant's main psychoactive compound responsible for the "high." But unlike THC, which is also the only compound deemed illegal in the United States, the remaining compounds do not produce a high. This past June, the U.S. Food and Drug Administration approved Epidiolex- the first pharm
9/20/18 - Patronise Only Registered Drug Outlets to Avoid Quackery, PCN Advises Public
Following high rate of fake drugs in circulation, Drug Distribution Inspection Committee and Enforcement, an arm of the Pharmacists Council of Nigeria, has urged Nigerians to patronise only registered drugs outlets. Thus, the organisation has embarked on an enforcement campaign across the nation in fulfillment of the mandate of ensuring that minimu
9/19/18 - After OTC, Focus Should Be on Clinical Hearing Services, Says JAMA Article
Given that the Over-the-Counter (OTC) Hearing Aid Act of 2017 is now law and a new FDA class of OTC hearing aids will be established by the end of 2020, efforts should now focus on ensuring that older adults also have access to affordable hearing care services, write Nicholas Reed, Frank Lin, and Amber Willink, PhD, in the September 13 JAM
9/19/18 - Alliance Pharma plc (LON:APH) had its Add rating reiterated by Numis Securities
Analyst Ratings For Alliance Pharma plc (LON:APH) Today, Numis Securities reiterated its Add rating on Alliance Pharma plc (LON:APH). There are 1 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Alliance Pharma plc (LON:APH) is Buy with a consensus target price of GBX [?] The post A
9/19/18 - Alliance Pharma plc (LON:APH) had its Add rating reiterated by Numis Securities with a GBX 115 price target
Analyst Ratings For Alliance Pharma plc (LON:APH) Today, Numis Securities reiterated its Add rating on Alliance Pharma plc (LON:APH) with a price target of GBX 115. There are 1 Hold Ratings, 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. The current consensus rating on Alliance Pharma plc (LON:APH) is Buy [?] The post Allianc
9/19/18 - CHPA Submits Comments to FDA Regarding Innovative Approaches for Nonprescription Drugs
Today, the Consumer Healthcare Products Association issued the following statement upon submitting comments to the Food and Drug Administration regarding its draft guidance titled,' Innovative Approaches for Nonprescription Drug Products.'. 'CHPA is committed to empowering consumer self-care by expanding choice and availability of safe, effective,
9/19/18 - Sunovion Announces Health Canada Approval of Aptiom (eslicarbazepine acetate) as Adjunctive Therapy for the Treatment of Partial-Onset Seizures in Adolescents and Children Above Six Years of Age
Sunovion Pharmaceuticals Inc. today announced that Health Canada approved the Supplemental New Drug Submission to expand the indication for its antiepileptic drug Aptiom to include use as an adjunctive therapy for the treatment of partial-onset seizures in adolescents and children above six years of age who are not satisfactorily controlled with
9/17/18 - C3 International Introduces Idrasil: the First Standardized Form of Prescription Medical Cannabis in a Pill
C3 International, a biopharmaceutical company that has played a leadership role in the emerging cannabinoid therapeutics health sector, today officially announced the launch of its flagship Idrasil pain management pill. Idrasil is the first standardized form of medical cannabis. It offers all of the medicinal analgesic and therapeutic benef
9/17/18 - Patent Application Titled "Topical Avermectin Formulations And Methods For Elimination And Prophylaxis Of Susceptible And Treatment Resistant Strains...
Patent Application Titled "Topical Avermectin Formulations And Methods For Elimination And Prophylaxis Of Susceptible And Treatment Resistant Strains Of Head Lice" Published Online. By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent applicatio
9/17/18 - Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium Multi-Symptom Relief
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced that it has received final approval from the U.S. Food& Drug administration for the store brand over-the-counter equivalent of Imodium Multi-Symptom Relief. Retail sales for the last 12 months were approximately $62 million as measured by IRI.
9/17/18 - Researchers Submit Patent Application, "Novel Device", for Approval (USPTO 20180244451)
By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors BUNCE, Martin; CHEN, Dan; SILVESTRI, Gabriella, filed on August 25, 2016, was made available online on August 30, 2018. The patent's assignee is Novartis Consumer Health S.A.. News editors obtain
9/17/18 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's global efforts to help assure product quality and transparency at foreign drug...
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency's global efforts to help assure product quality and transparency at foreign drug manufacturing facilities. By a News Reporter-Staff News Editor at Pharma Business Week Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landsc
Articles(s): 1 - 17 of 17     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415